Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast CancerClin. Cancer Res 2023 May 01;29(9)1719-1729, AA Davis, J Luo, T Zheng, C Dai, X Dong, L Tan, R Suresh, FO Ademuyiwa, C Rigden, TP Rearden, K Clifton, K Weilbaecher, A Frith, PK Tandra, T Summa, B Haas, S Thomas, LF Hernandez-Aya, LL Peterson, X Wang, SJ Luo, K Zhou, P Du, S Jia, BL King, J Krishnamurthy, CX Ma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.